DexCom (DXCM) Tops Q4 EPS by 7c

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.10, $0.07 better than the analyst estimate of $0.03. Revenue for the quarter came in at $221 million versus the consensus estimate of $215.87 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance